Blog
RSS FeedPosted by Michael Wonder on 22 Nov 2019
Speaker Pelosi’s drug pricing plan could result in 56 fewer new medicines over 10 years
21 November 2019 - International reference pricing provisions in plan would decimate development of innovative medicines by nearly 90%. ...
Posted by Michael Wonder on 19 Nov 2019
Here’s why pharmaceutical companies raise their prices so much
19 November 2019 - Yes, I’ve ranted about healthcare prices before. On more than one occasion. ...
Posted by Michael Wonder on 14 Nov 2019
Drug companies exaggerate — controlling drug prices won't threaten innovation
13 November 2019 - It is hard to not be impressed by the progress Americans have made in combatting diseases. ...
Posted by Michael Wonder on 26 Oct 2019
Public sector financial support for late stage discovery of new drugs in the United States: cohort study
23 October 2019 - This study determined the extent to which late stage development of new drugs relies on support from ...
Posted by Michael Wonder on 25 Oct 2019
Making new drugs is hard. So is pricing them.
25 October 2019 - What's harder, making new drugs, or pricing them? ...
Posted by Michael Wonder on 22 Oct 2019
Can we stop the medicine arms race?
22 October 2019 - Patients at risk of “exploitative manipulation” from medicines lobbyists if PBS politicisation continues, doctor tells parliament ...
Posted by Michael Wonder on 17 Oct 2019
Pelosi’s drug pricing plan puts medical innovation at risk
17 October 2019 - The future of medical innovation in America is at a crossroads. ...
Posted by Michael Wonder on 12 Oct 2019
California’s new transparency law shows staggering rise in wholesale drug prices
11 October 2019 - Drug makers fought hard against California’s groundbreaking drug price transparency law, passed in 2017. Now, state ...
Posted by Michael Wonder on 11 Oct 2019
Pharma industry is 'right in the crosshairs,' Merck CEO Kenneth Frazier says
11 October 2019 - President Donald Trump and House Speaker Nancy Pelosi are in a battle over impeachment but their ...
Posted by Michael Wonder on 10 Oct 2019
PhRMA CEO warns Pelosi bill to lower drug prices would be 'devastating' for industry
10 October 2019 - The head of the main pharmaceutical industry lobbying group on Thursday warned that a bill to ...
Posted by Michael Wonder on 08 Oct 2019
FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases
8 October 2019 - The U.S. FDA today announced that it has awarded 12 new clinical trial research grants totaling ...
Posted by Michael Wonder on 07 Oct 2019
‘It shows how much pharma has on their plate’: Congress just quietly passed a bill that will cost drug makers $3 billion.
4 October 2019 - It’s on the lips of every presidential candidate, Speaker Nancy Pelosi, and even President Trump: It’s ...
Posted by Michael Wonder on 05 Oct 2019
Is Congress too afraid to fight big pharma?
4 October 2019 - Millions of Americans are struggling to afford their prescription drugs. Big Pharma corporations are enjoying billions ...
Posted by Michael Wonder on 17 Sep 2019
With ominous TV spots and a senior ‘strike force,’ AARP launches an all-out attack on pharma
17 September 2019 - As beachgoers soaked up the sun on a balmy August day in Ocean City, Md., single-engine ...
Posted by Michael Wonder on 14 Sep 2019
Right to try ‘remains a bust,’ as many drug makers prefer FDA reviews
12 September 2019 - Despite the hubbub over the “right-to-try” law, a recent survey found that nearly half of drug ...